Viewed: 230
Emailed: 0
PDF Downloaded: 603
Full Text PDF Share on Facebook Share on Twitter
Original Article
Author Details :
Volume : 13, Issue : 2, Year : 2023
Article Page : 277-283
https://10.18231/j.pjms.2023.054
Abstract
Background: Transversus abdominis plane (TAP) block provides a novel approach for analgesia in abdominal surgery by blocking the sensory nerve supply of the anterior abdominal wall. We evaluated the analgesic efficacy of TAP block with ropivacaine in patients undergoing total abdominal hysterectomy (TAH).
Materials and Methods: 60 adult patients of ASA Grade 1 and 2 undergoing elective TAH were randomized into two groups in this double blind study. All patients received a standard general anaesthetic and before the surgical incision, a bilateral TAP block using the landmark technique was performed with 15 to 20 mlof 0.375% ropivacaine (maximum dose 3mg/kg) (Group R) or saline (Group C). Assessment of hemodynamic parameters and requirement of vecuronium and opioids was noted intraoperatively. Postoperative assessment of pain was performed at regular intervals using visual analog scale (VAS) and categorical pain score (CPS), and total analgesics administered over 48 hrs were noted.
Results : Intraoperative hemodynamic parameters showed significantly lower mean values in the ropivacaine group till 50 minutes and from 80 to 120 minutes after the surgical incision. (p value<0 p=0.000). p=0.000), p=0.004) p=0.007) postoperatively(p=0.000).>
Conclusion: TAP block with ropivacaine provides effective intraoperative analgesia and decreases postoperative analgesic requirement till 48hours in patients undergoing total abdominal hysterectomy.
Keywords: TAP block, total abdominal hysterectomy, Ropivacaine
How to cite : Sharma V, Talwar V, Mudgal P, Transversus abdominis plane block with ropivacaine provides effective analgesiain patients undergoing total abdominal hysterectomy. Panacea J Med Sci 2023;13(2):277-283
Copyright © 2023 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)